Novel Mitochondrial Biomarkers Identified for Atrial Fibrillation Through Integrated Bioinformatics Analysis

A comprehensive bioinformatics analysis has identified three novel mitochondria-associated endoplasmic reticulum membrane (MAM)-related biomarkers that could revolutionize the diagnosis and treatment of atrial fibrillation (搜索)搜索该疾病 (AF), the most prevalent cardiac arrhythmia affecting millions worldwide.

Breakthrough Discovery in AF Pathogenesis

Researchers conducted an integrated analysis combining multiple gene expression datasets, machine learning algorithms, and experimental validation to uncover the role of MAM dysfunction in AF development. The study identified TP53 (搜索)搜索该靶点, MAPKAPK5 (搜索)搜索该靶点, and HLA-G (搜索)搜索该靶点 as key biomarkers that are significantly upregulated in AF patients compared to healthy controls.

"Atrial fibrillation (搜索)搜索该疾病 accounts for approximately one-third of all hospitalizations due to arrhythmias, with global prevalence ranging from 1% to 2% and increasing with age," the researchers noted. Despite various available treatments, outcomes remain unsatisfactory, particularly in persistent AF patients who exhibit high long-term recurrence rates.

MAM Dysfunction: A New Therapeutic Target

The mitochondria-associated endoplasmic reticulum membranes represent a critical interface for cellular communication, regulating calcium homeostasis, mitochondrial dynamics, and cellular stress responses. The study revealed that MAM-related proteins play significant roles in cardiovascular diseases, but their connection to AF had remained largely unexplored.

Through weighted gene co-expression network analysis (WGCNA) of multiple datasets, researchers identified 18 AF-related MAM genes. Using machine learning approaches including support vector machine-recursive feature elimination (SVM-RFE) and least absolute shrinkage and selection operator (LASSO) regression, they narrowed this down to three key biomarkers.

Causal Relationship Established Through Mendelian Randomization

The study employed Mendelian randomization analysis to establish causal relationships between the identified biomarkers and AF onset. MAPKAPK5 (搜索)搜索该靶点 emerged as a significant causal risk factor, with an odds ratio of 1.065 (95% CI = 1.009–1.125, P = 0.022). The analysis showed no evidence of heterogeneity or horizontal pleiotropy, confirming the reliability of these findings.

Immune System Dysregulation Revealed

A striking finding was the extensive immune cell infiltration observed in AF patients. The analysis revealed significantly increased infiltration of 18 immune cell types in the AF group compared to controls, including macrophages, activated dendritic cells, neutrophils, and monocytes.

All three biomarkers demonstrated strong positive correlations with these immune cells, with the highest correlation observed between TP53 (搜索)搜索该靶点 and monocytes (correlation = 0.91, P = 7.495e-12). Notably, myeloid-derived suppressor cells showed exceptionally high correlations with all biomarkers (correlation >0.95), suggesting a crucial role in AF pathogenesis.

Functional Pathways and Mechanisms

Gene set enrichment analysis revealed that the three biomarkers are involved in multiple immune-related pathways, including cytokine-cytokine receptor interaction, chemokine signaling pathway, Toll-like receptor signaling pathway, and MAPK signaling pathway. The biomarkers also participate in metabolism-related pathways, including glycerophospholipid metabolism and propanoate metabolism.

Single-cell RNA sequencing analysis identified six distinct cell types in AF tissue, with mononuclear phagocytes and dendritic cells accounting for the highest proportion. The analysis revealed differential expression patterns of TP53 (搜索)搜索该靶点 and MAPKAPK5 (搜索)搜索该靶点 across various cell types, with significant differences observed in lymphoid cells, neutrophils, and endothelial cells.

Therapeutic Implications and Drug Predictions

The researchers identified potential therapeutic targets through drug-gene interaction analysis. Simvastatin查看药品详情, a commonly used statin, showed strong binding affinity with HLA-G (搜索)搜索该靶点 through hydrogen bonding (docking energy of −5.74 kcal/mol). This finding aligns with previous research suggesting that statins may have beneficial effects in AF prevention and treatment due to their anti-inflammatory and antioxidative properties.

Experimental Validation Confirms Findings

To validate their computational findings, researchers established an AF model using rapid atrial pacing in canines. Electrophysiological measurements confirmed successful AF induction, with significantly higher induction times and duration in the AF model compared to controls.

Both Western blotting and quantitative real-time PCR analysis demonstrated significant upregulation of all three biomarkers (TP53 (搜索)搜索该靶点, MAPKAPK5 (搜索)搜索该靶点, and HLA-G (搜索)搜索该靶点) in the canine AF model at both protein and mRNA levels. This experimental validation strengthens confidence in the differential expression of these genes in AF pathogenesis.

Clinical Significance and Future Directions

The study developed a nomogram based on the three biomarkers that showed high accuracy for AF prediction, with area under the ROC curve values of 0.821 in the training set and 1.0 in the validation set. The calibration curves and decision curve analysis confirmed the nomogram's robust predictive performance.

The researchers emphasized that their findings provide new insights into the molecular mechanisms underlying AF and offer potential targets for clinical diagnosis and treatment. The identification of MAM dysfunction as a key pathway in AF pathogenesis opens new avenues for therapeutic intervention.

However, the study acknowledges limitations, including the relatively small sample size and the need for validation in larger, multi-center cohorts. Future research will focus on functional experiments and clinical trials to further explore the therapeutic potential of these biomarkers and corresponding drugs.

The integration of MAM dysfunction, immune dysregulation, and atrial remodeling represents a paradigm shift in understanding AF pathogenesis, potentially leading to more effective personalized treatment strategies for this challenging cardiovascular condition.